Absolute choline tissue concentration mapping for prostate cancer localization and characterization using 3D 1H MRSI without water‐signal suppression
Open Access
- 23 September 2021
- journal article
- research article
- Published by Wiley in Magnetic Resonance in Medicine
- Vol. 87 (2) , 561-573
Abstract
Purpose: Until now, 1H MRSI of the prostate has been performed with suppression of the large water signal to avoid distortions of metabolite signals. However, this signal can be used for absolute quantification and spectral corrections. We investigated the feasibility of water‐unsuppressed MRSI in patients with prostate cancer for water signal–mediated spectral quality improvement and determination of absolute tissue levels of choline.Methods: Eight prostate cancer patients scheduled for radical prostatectomy underwent multi‐parametric MRI at 3 T, including 3D water‐unsuppressed semi‐LASER MRSI. A postprocessing algorithm was developed to remove the water signal and its artifacts and use the extracted water signal as intravoxel reference for phase and frequency correction of metabolite signals and for absolute metabolite quantification.Results: Water‐unsuppressed MRSI with dedicated postprocessing produced water signal and artifact‐free MR spectra throughout the prostate. In all patients, the absolute choline tissue concentration was significantly higher in tumorous than in benign tissue areas (mean ± SD: 7.2 ± 1.4 vs 3.8 ± 0.7 mM), facilitating tumor localization by choline mapping. Tumor tissue levels of choline correlated better with the commonly used (choline + spermine + creatine)/citrate ratio (r = 0.78 ± 0.1) than that of citrate (r = 0.21 ± 0.06). The highest maximum choline concentrations occurred in high‐risk cancer foci.Conclusion: This report presents the first successful water‐unsuppressed MRSI of the whole prostate. The water signal enabled amelioration of spectral quality and absolute metabolite quantification. In this way, choline tissue levels were identified as tumor biomarker. Choline mapping may serve as a tool in prostate cancer localization and risk scoring in multi‐parametric MRI for diagnosis and biopsy procedures.Keywords
This publication has 44 references indexed in Scilit:
- Choline metabolism in malignant transformationNature Reviews Cancer, 2011
- A phase and frequency alignment protocol for 1H MRSI data of the prostateNMR in Biomedicine, 2011
- Correlation of phospholipid metabolites with prostate cancer pathologic grade, proliferative status and surgical stage – impact of tissue environmentNMR in Biomedicine, 2011
- Correlation of ADC and T2 Measurements With Cell Density in Prostate Cancer at 3.0 TeslaInvestigative Radiology, 2009
- Quantification of choline‐ and ethanolamine‐containing metabolites in human prostate tissues using 1H HR‐MAS total correlation spectroscopyMagnetic Resonance in Medicine, 2008
- Short echo time 1H‐MRSI of the human brain at 3T with minimal chemical shift displacement errors using adiabatic refocusing pulsesMagnetic Resonance in Medicine, 2007
- New method for the simultaneous detection of metabolites and water in localized in vivo 1H nuclear magnetic resonance spectroscopyMagnetic Resonance in Medicine, 2005
- Optimal timing for in vivo 1H‐MR spectroscopic imaging of the human prostate at 3TMagnetic Resonance in Medicine, 2005
- Quantification of citrate concentration in the prostate by proton magnetic resonance spectroscopy: Zonal and age‐related differencesMagnetic Resonance in Medicine, 1996
- Numerical Hilbert transform and automatic phase correction in magnetic resonance spectroscopyJournal of Magnetic Resonance (1969), 1969